timothy c barabe  san francisco ca  intelius sign in we found timothy c barabe in san francisco ca timothy c barabe intelius found that timothy c barabe is a male between  and  years old from san francisco ca we have connected them to  addresses  phones and  relatives or associates also known as timothy craig barabe tim barabe get report now age timothy c barabe is in his s timothy has lived in san francisco ca westport ct tybee island ga timothys relatives gregory barabe gailyn kennedy deborah barabe debbie barabe timothy c barabe zodiac signpisces gendermale professional status chief financial officer at human genome sciences  inc get report now want to know more about timothy get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about timothy or use our people search engine to find others get background check on timothy c barabe get a criminal check on timothy c barabe get a public record report on timothy c barabe get a people search report on timothy c barabe timothy c barabes contact information known cities lived in find out where timothy c barabe has lived as well as timothy c barabes phone numbers and email addresses timothy c barabe has lived in  states california address for timothy c barabe  s f p san francisco ca has lived in san francisco ca westport ct get full address report phone numbers associated with timothy c barabe    rockville md    santa clara ca    duluth ga get full phone report email addresses associated with timothy c barabe btcom tecom tecom get email report timothy c barabes professional information information regarding timothy c barabes professional history find out previous places timothy c barabe has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act timothy c barabe has worked at  places company human genome sciences  inc title chief financial officer company human genome sciences  inc title senior vice president and chief financial officer timothy c barabes experience title chief financial officer company human genome sciences  inc job details the mission of hgs is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs the hgs clinical development pipeline includes novel drugs to treat hepatitis c lupus anthrax disease cancer and other immunemediated diseases the companys primary focus is rapid progress toward the commercialization of its two key lead drugs albuferon® for hepatitis c and lymphostatb belimumab for lupus phase  clinical trials of both drugs are ongoing abthrax® raxibacumab is in latestage development for the treatment of anthrax disease and the company is on track to begin the delivery in  of  doses of abthrax to the strategic national stockpile under a contract entered into with the us government in june  other hgs drugs in clinical development include two trail receptor antibodies for the treatment of cancers title senior vice president and chief financial officer company human genome sciences  inc job details company size less than  mil the mission of hgs is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs the hgs clinical development pipeline includes novel drugs to treat hepatitis c lupus anthrax disease cancer and other immunemediated diseases the companys primary focus is rapid progress toward the commercialization of its two key lead drugs albuferon® for hepatitis c and lymphostatb belimumab for lupus phase  clinical trials of both drugs are ongoing abthrax® raxibacumab is in latestage development for the treatment of anthrax disease and the company is on track to begin the delivery in  of  doses of abthrax to the strategic national stockpile under a contract entered into with the us government in june  other hgs drugs in clinical development include two trail receptor antibodies for the treatment of cancers additional professional information on timothy c barabe see timothy c barabes linkedin profile timothy c barabes social network and potential email matches find out potential social network profiles and potential email usernamed for timothy c barabe timothy c barabes known social networks and potential email matches find all of timothy c barabes social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches timothy barabe username matches timothybarabe barabetimothy timothybarabe barabetimothy timothybarabe barabetimothy timothybarabe barabetimothy tbarabe popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches t barabe intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here selecta biosciences appoints timothy c barabe to board of directors nasdaqselb english français register sign in selecta biosciences appoints timothy c barabe to board of directors august    et  source selecta biosciences inc watertown mass aug   globe newswire  selecta biosciences inc nasdaqselb a clinicalstage biopharmaceutical company developing targeted antigenspecific immune therapies for rare and serious diseases today announced the election of timothy c barabe to the company’s board of directors most recently serving as chief financial officer and executive vice president at affymetrix inc mr barabe has extensive experience in the life sciences industry having held a broad range of financial and strategic roles “we are very pleased to welcome tim to our board tim is an industry veteran with decades of strong strategic and financial experience in the life sciences industry” said werner cautreels phd chairman ceo and president of selecta biosciences “tim’s exceptional grasp of the commercial and financial opportunities and challenges entailed in financing and growing selecta will add significant strategic perspectives as we seek to advance candidates from selecta’s pipeline portfolio in development” “i am very excited to be joining selecta’s board of directors at this pivotal time as the company applies its novel technologies to generate a robust pipeline of candidates” said mr barabe “selecta’s novel immune therapies offer significant opportunities for the company to provide patients providers and payors with meaningful new treatment options to address rare and serious diseases” mr barabe has more than  years of experience in the life sciences industry he served as the chief financial officer and executive vice president at affymetrix inc where he led the company’s financial functions as well as the treasury investor relations and information technology departments previously he served as senior vice president and chief financial officer at human genome sciences where he was responsible for working with the leadership team to drive the financial strategy and operations of the company for more than  years he held senior international executive roles in finance general management and strategic planning at novartis ag one of the world’s largest pharmaceutical companies his roles included chief financial officer of the sandoz generics business unit president of the ciba vision corporation specialty lens business franchise and group vice president and chief financial officer of ciba vision corporation mr barabe has a bba in finance from the university of massachusetts amherst and an mba from the university of chicago he also serves as a director of several public company boards including arqule opexa therapeutics and vigilant biosciences about selectaselecta biosciences inc is a clinicalstage biopharmaceutical company developing targeted therapies that use immunomodulators encapsulated in nanoparticles to induce antigenspecific immune responses to prevent and treat disease selecta’s proprietary synthetic vaccine particle svp technology is a highly flexible nanoparticle platform capable of incorporating a wide range of antigens and immunomodulators allowing the svp products to either induce antigenspecific tolerance or activate the immune system selectas focus is on developing and commercializing differentiated therapies that are designed to modulate the immune system to effectively and safely treat rare diseases by mitigating the formation of antidrug antibodies adas in response to lifesustaining biologic drugs toleranceinducing svp products also have potential applications in the treatment of allergies and autoimmune diseases selecta is also developing svp products that activate the immune system to prevent and treat cancer infections and other diseases selecta is based in watertown massachusetts usa forwardlooking statementsthis press release contains forwardlooking statements within the meaning of the private securities litigation reform act of 99 all statements contained in this press release that do not relate to matters of historical fact should be considered forwardlooking statements including without limitation statements regarding the impact of mr barabe’s appointment on our business and the treatment potential of our product candidates these forwardlooking statements are based on management’s current expectations these statements are neither promises nor guarantees but involve known and unknown risks uncertainties and other important factors that may cause our actual results performance or achievements to be materially different from any future results performance or achievements expressed or implied by the forwardlooking statements including but not limited to the following we have incurred significant losses and may never become profitable our need for additional funding which may not be available our limited operating history operating and financial restrictions from our credit facility and the charter of our russian subsidiary limitations on our ability to offset future tax income the early stage of clinical development for our product candidates the unproven approach of our svp technology our failure to capitalize on more profitable candidates or indications the lengthy and expensive process of clinical drug development which has an uncertain outcome potential delays in enrollment of patients which could affect the receipt of necessary regulatory approvals potential delays in regulatory approval which would impact the ability to commercialize our product candidates and affect our ability to generate revenue our potential inability to receive orphan drug designation any fast track or breakthrough therapy designation may not lead to faster development or regulatory or marketing approval undesirable side effects of our product candidates which could negatively impact regulatory approval or commercialization our reliance on third parties to manufacture our product candidates including sbio our sole supplier of pegsiticase our inability to maintain our existing or future collaborations or licenses our reliance on third parties to conduct our clinical trials and the potential for those third parties to not perform satisfactorily our lack of experience in manufacturing our product candidates on a commercial scale the potential failure of our product candidates to achieve market acceptance our lack of experience selling marketing and distributing products and our lack of internal capability to do so failure of our product candidates to offer material commercial advantages over other treatments failure to compete successfully against other drug companies unfavorable pricing regulations thirdparty coverage or reimbursement policies product liability lawsuits failure to obtain marketing approval internationally compliance with healthcare laws and regulations recently enacted or future legislation postmarketing restrictions or withdrawal from the market compliance with export and import controls sanctions embargoes anticorruption and antimoney laundering laws and regulations strict price controls imposed by foreign governments compliance with environmental health and safety laws and regulations negative public opinion or increased regulatory scrutiny of gene therapy and genetic research our ability to protect our proprietary technology and intellectual property and limitations of that protection failure to identify or correctly interpret patents relevant to our business our ability to protect the confidentiality of our trade secrets and knowhow changes in united states patent law intellectual property infringement lawsuits our patents being found invalid or unenforceable obtaining and maintaining patents claims challenging the inventorship or ownership of our patents and other intellectual property failure to comply with intellectual property licenses and funding arrangements our inability to obtain or maintain necessary rights through acquisitions or inlicenses claims that we or our employees misappropriated intellectual property or claiming ownership of our intellectual property adequate protection of our trademarks and tradenames ability to obtain fda approval of product names competition from biosimilars ability to attract and retain key executives and qualified personnel managing our growth could result in difficulties risks associated with operating in russia including sanctions and internationally potential system failures misconduct of our employees or contracted third parties the effects of acquisitions or joint ventures substantial fluctuation in the price of our common stock our executive officers directors and principal stockholders have the ability to control or significantly influence matters submitted to stockholders a drop in share price due to the significant portion of our total outstanding shares eligible to be sold into the market being an “emerging growth company” costs and resources of operating as a public company unfavorable or no analyst research or reports and securities class action litigation against us  these and other important factors discussed under the caption “risk factors” in our final prospectus filed with the securities and exchange commission or sec on june   relating to our registration statement on form s and our other reports filed with the sec could cause actual results to differ materially from those indicated by the forwardlooking statements made in this press release any such forwardlooking statements represent management’s estimates as of the date of this press release while we may elect to update such forwardlooking statements at some point in the future we disclaim any obligation to do so even if subsequent events cause our views to change these forwardlooking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release media contact kathryn morris the yates network 9 kathryntheyatesnetworkcom investor contact stephanie ascher stern investor relations inc  stephaniesternircom related articles other press releases by selecta biosciences selecta biosciences announces  million private placement june    selecta biosciences announces addition of patrick j zenner to board of directors june 9   selecta biosciences reports data from ongoing phase  trial of lead candidate sel in development for chronic severe gout june    selecta biosciences announces upcoming clinical presentations june    selecta biosciences to present at the jefferies global healthcare conference on june   may     other news releases in directors and officers in the last  days profile selecta biosciences   subscribe via rss  subscribe via atom  javascript watertown massachusetts united states contact data media contact kathryn morris the yates network 9 kathryntheyatesnetworkcom investor contact stephanie ascher stern investor relations inc  stephaniesternircom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files selecta biosciences logo logo url  copy the link below formats available original medium small newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved veev timothy c barabe insider trades for veeva systems inc cl a bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close veeva systems inc cl a nyse veev go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus veeva systems inc cl a after hours  quotes are delayed by  min jul    pm veev quoteszigmancomposite   change  9 volume volume 9 quotes are delayed by  min quoteszigmancomposite previous close  9   change  9 day low day high 9 9  week low  week high   insider activity individual timothy c barabe mr timothy c barabe is independent director at opexa therapeutics inc and independent director at arqule inc he is on the board of directors at veeva systems inc vigilant biosciences inc opexa therapeutics inc arqule inc and project open hand inc mr barabe was previously employed as chief financial officer  executive vice president by affymetrix inc chief financial officer  senior vice president by human genome sciences inc managing directorunited kingdom by mölnlycke health care group ab chief financial officer by regent medical ltd presidentspecialty lens business franchise by ciba vision corp finance director by cibageigy corp and chief financial officer by sandoz international gmbh he received his undergraduate degree from the university of massachusetts and an mba from the university of chicago transactions date shares transaction value  9   derivativenonderivative trans at  per share   9   disposition at  per share   9   derivativenonderivative trans at  per share   9   disposition at  per share   9   derivativenonderivative trans at  per share  9 9   derivativenonderivative trans at  per share  9    derivativenonderivative trans at  per share  9    derivativenonderivative trans at  per share  9    derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr gordon ritter chairman mr peter p gassner chief executive officer  director mr matthew j wallach president mr mitch wallace vice presidentoperations mr timothy stephen cabral chief financial officer mr doug ostler vice presidentcrm products  technology mr henry levy chief strategy officer mr dan goldsmith chief strategy officer dr jacques mourrain senior directorquality  compliance ms avril england general managerveeva vault mr steve harper directorproduct management vault platform mr mark t carges director mr paul shawah senior vice presidentcommercial strategy ms eleni nitsa zuppas chief marketing officer  headmedia contacts mr alan v mateo executive vice presidentglobal sales mr rick lund directorinvestor relations ms lisa barbadora headpublic relations mr jonathan faddis secretary senior vice president  general counsel mr paul e chamberlain independent director mr paul jai sekhri independent director mr ronald e f codd independent director mr timothy c barabe independent director trending tickers quoteszigman9composite vuzi quoteszigmancomposite jcp quoteszigman99composite nugt9 quoteszigman9composite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service 9pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now loading more headlines dow quoteszigman9realtime    nasdaq quoteszigman9realtime    sp  quoteszigmanrealtime  9  kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml  99 99 lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  timothy c barabe board dir arqule inc a publisher of business information since 9        search business search executive   advanced search   sign in    hints profile of timothy barabe   timothy barabe   board dir  arqule inc   timothy barabe email  please login   company name  arqule inc   company website  wwwarqulecom   company address  9 presidential way woburn maunited states   timothy barabe profile  board dir  arqule inc   timothy barabe biography  timothy c barabe has been a director since november  mr barabe is currently senior vice president and chief financial officer of human genome sciences previously he was with regent medical ltd a ukbased privately owned surgical supply company where he served as chief financial officer from  mr barabe served with novartis ag from 9 in a succession of senior executive positions in finance general management and strategic planning most recently as the chief financial officer of sandoz gmbh the generic pharmaceutical subsidiary of novartis mr barabe received his bba from the university of massachusetts amherst and his mba from the university of chicago   timothy barabe colleagues  name title email werner cautreels member  scientific advisory board please login william messenger board dir please login ronald lindsay board dir please login anthony messina vp  human development please login peter lawrence pres coo please login             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory      � 9 walkerss research  a publisher of business information since 9 all rights reserved selecta biosciences appoints timothy c barabe to board of directors  pg  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use 99 thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street selecta biosciences appoints timothy c barabe to board of directors globenewswire aug    am edt about selectaselecta biosciences inc is a clinicalstage biopharmaceutical company developing targeted therapies that use immunomodulators encapsulated in nanoparticles to induce antigenspecific immune responses to prevent and treat disease selectas proprietary synthetic vaccine particle svp technology is a highly flexible nanoparticle platform capable of incorporating a wide range of antigens and immunomodulators allowing the svp products to either induce antigenspecific tolerance or activate the immune system selectas focus is on developing and commercializing differentiated therapies that are designed to modulate the immune system to effectively and safely treat rare diseases by mitigating the formation of antidrug antibodies adas in response to lifesustaining biologic drugs toleranceinducing svp products also have potential applications in the treatment of allergies and autoimmune diseases selecta is also developing svp products that activate the immune system to prevent and treat cancer infections and other diseases selecta is based in watertown massachusetts usa forwardlooking statementsthis press release contains forwardlooking statements within the meaning of the private securities litigation reform act of 99 all statements contained in this press release that do not relate to matters of historical fact should be considered forwardlooking statements including without limitation statements regarding the impact of mr barabes appointment on our business and the treatment potential of our product candidates these forwardlooking statements are based on managements current expectations these statements are neither promises nor guarantees but involve known and unknown risks uncertainties and other important factors that may cause our actual results performance or achievements to be materially different from any future results performance or achievements expressed or implied by the forwardlooking statements including but not limited to the following we have incurred significant losses and may never become profitable our need for additional funding which may not be available our limited operating history operating and financial restrictions from our credit facility and the charter of our russian subsidiary limitations on our ability to offset future tax income the early stage of clinical development for our product candidates the unproven approach of our svp technology our failure to capitalize on more profitable candidates or indications the lengthy and expensive process of clinical drug development which has an uncertain outcome potential delays in enrollment of patients which could affect the receipt of necessary regulatory approvals potential delays in regulatory approval which would impact the ability to commercialize our product candidates and affect our ability to generate revenue our potential inability to receive orphan drug designation any fast track or breakthrough therapy designation may not lead to faster development or regulatory or marketing approval undesirable side effects of our product candidates which could negatively impact regulatory approval or commercialization our reliance on third parties to manufacture our product candidates including sbio our sole supplier of pegsiticase our inability to maintain our existing or future collaborations or licenses our reliance on third parties to conduct our clinical trials and the potential for those third parties to not perform satisfactorily our lack of experience in manufacturing our product candidates on a commercial scale the potential failure of our product candidates to achieve market acceptance our lack of experience selling marketing and distributing products and our lack of internal capability to do so failure of our product candidates to offer material commercial advantages over other treatments failure to compete successfully against other drug companies unfavorable pricing regulations thirdparty coverage or reimbursement policies product liability lawsuits failure to obtain marketing approval internationally compliance with healthcare laws and regulations recently enacted or future legislation postmarketing restrictions or withdrawal from the market compliance with export and import controls sanctions embargoes anticorruption and antimoney laundering laws and regulations strict price controls imposed by foreign governments compliance with environmental health and safety laws and regulations negative public opinion or increased regulatory scrutiny of gene therapy and genetic research our ability to protect our proprietary technology and intellectual property and limitations of that protection failure to identify or correctly interpret patents relevant to our business our ability to protect the confidentiality of our trade secrets and knowhow changes in united states patent law intellectual property infringement lawsuits our patents being found invalid or unenforceable obtaining and maintaining patents claims challenging the inventorship or ownership of our patents and other intellectual property failure to comply with intellectual property licenses and funding arrangements our inability to obtain or maintain necessary rights through acquisitions or inlicenses claims that we or our employees misappropriated intellectual property or claiming ownership of our intellectual property adequate protection of our trademarks and tradenames ability to obtain fda approval of product names competition from biosimilars ability to attract and retain key executives and qualified personnel managing our growth could result in difficulties risks associated with operating in russia including sanctions and internationally potential system failures misconduct of our employees or contracted third parties the effects of acquisitions or joint ventures substantial fluctuation in the price of our common stock our executive officers directors and principal stockholders have the ability to control or significantly influence matters submitted to stockholders a drop in share price due to the significant portion of our total outstanding shares eligible to be sold into the market being an emerging growth company costs and resources of operating as a public company unfavorable or no analyst research or reports and securities class action litigation against us  trending trump just resurrected the ugly practice known as civil forfeiture for no reason ftc seen as set to block rite aid deal sears just surrendered to amazon with kenmore deal  reasons dying sears had to strike a deal with the ruthless amazon starbucks has an alarming problem that even its fans must admit has to be fixed  and soon advertising partners 99 thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers timothy c barabe   san francisco ca  mylifecom™ background profile search for your public page first name last name city search all fields are required already a member log in about  contact info photos  social posts reviews  ratings court  arrestrecords friends  family tb view photos editremove timothy barabe san francisco ca age   9 aka barbara timothy thimothy c barabe timothy c basabe timothy barofe timothy craig barabe timothy n barabe timothy c baraby tim barabe timothy c barabe timothy c barbara executive vice president  chief financial officer at affymetrix marital status unavailable politics education info editremove my info view full contact info  or  view full background details reputation score    review rate timothy improve my rating    ask others to rate ranking compared to us population bad poor fair good editremove my info contact info   view email address    send message 9   san francisco ca 9 view full contact details  or  view full background details   more summary summary currently lives in san francisco  ca before that lived in san francisco  ca is related to anne barabe about  contact information timothys story summary currently lives in san francisco  ca before that lived in san francisco  ca is related to anne barabe contact information this section includes information on addresses phone numbers and email addresses recent address 9   san francisco ca view address past address   st san francisco  ca view address past address    washington  dc view address past address 9  st san francisco  ca view address current phone number   view phone timothy may have hidden social profiles  photos  check full background report to see timothys social media activity this may contain online profiles dating websites forgotten social media accounts and other potentially embarrassing profiles this may also contain additional contact information giving you more ways to get in touch view full phone email  address details work history executive vice president  chief financial officer at affymetrix advisory board member retirement plan services at charles schwab view details school history timothy may have education information  check full background report to see possible education history including where and when they attending high school and college and a complete list of their high school class list view full background details properties timothy may have properties  check full background report to see a complete list of known properties this may contain information such as address market value purchase price and loan amount view full background details corporate affiliations timothy may have corporate affiliations  check full background report to see a complete list of known corporate affiliations this may contain information such as company name job title address and time period of service view full background details licenses and permits timothy may have licenses  permits  check full background report to see weapons permits federal aviation administration pilot licenses and drug enforcement administration licenses for prescribing controlled pharmaceuticals if applicable you will also see timothys license number and expiration date view full background details photos  social posts photos viewphotos timothy may have photos  check full background report to see possible pictures and photo albums found from social and public sources view full background details social posts view social posts we did not find any social posts records after searching multiple government records social and public sources as part of your premium service we will continue to search and notify you when we find new information timothy may have hidden social profiles  photos  check full background report to see timothys social media activity this may contain online profiles dating websites forgotten social media accounts and other potentially embarrassing profiles this may also contain additional contact information giving you more ways to get in touch reviews  ratings timothy barabes reputation score    review rate timothy improve my rating    ask others to rate    write a review ranking compared to us population bad poor fair good jeffrey tinsley ceo  founder of mylifecom personal review reply × showing balanced reviews improves the credibility of your positive reviews so consider keeping themare you sure you want to delete this comment yes no × your request has been sent close court  arrest records arrest and criminal records timothy may have arrest and criminal records  check full background report to see possible arrest or conviction records we have found on timothy this may include any duis traffic tickets and outstanding warrants when applicable we may show where the crime occurred and provide details about the offense view full background details sex offender status timothy may have sexual offenses  check full background report to see a complete list of any and all sex offenses timothy may have been convicted of and his current sex offender status if applicable view full background details lawsuits liens  bankruptcies timothy may have lawsuits liens  bankruptcies  check full background report to see local state and federal court documents sensitive legal information and any litigation that timothy may have been involved in well reveal arrest details like case numbers offense descriptions and booking dates where available view full background details family  friends relativesassociates ab anne barabe guilford ct tb timothy barabe atlanta ga view more relatives classmates timothy may have a record of associated classmates  check full background report to see possible who they are and full classlists found from school records and public sources view full background details neighborhood information  information based on current address age education level household income estimated home values top buying habits top interests  hobbies find another timothy barabe tb timothy barabe  gilbert az tb timothy barabe  atlanta ga view more a full background report includes find background profiles  reputation scores for everyone in the us mylife searches government social  public sources to pull together all details in one place contact details include addresses email phone numbers photos  social profiles and more background checks include arrest  court records education  work history personal reviews and more to asses anyones reputation only mylife helps you improve your background report  reputation score edit  correct your own background report to look your best to employers clients friends dates  others searching for you on google ask friends family employers  clients to review you to improve your public reputation score remove your information from sites you cant control to protect your privacy see what mylife customers are saying when considering new tenants you should always check and verify their background to feel secure  protected mylife makes it easy  ron w back to top × send message message sent an error has occurred please try again later how do you know this person please select used to notify recipient unknown college high school junior high school grade school met on mylifecom is my friend related to me mutual friend work club or organization religion affiliation not sure dont know them found you through a dating service found your service subject message addtrack contact send now × your message has been sent × help timothy build his reputation  public image thank you for rating timothy barabe please provide additional details to give people more insight into timothys reputation sorry we were unable to submit your review please select at least one quality does timothy have these qualities deselect all personal professional dating smart loyal honest good listener humble generous fun easy going optimistic kind i would not be friends with timothy i would be friends is there anything you want to say about on a personal level   optional responsible hardworking intelligent collaborative creative resourceful motivated flexible ambitious articulate i would not work with timothy is there anything you want to say about on a professional level   optional faithful respectful understanding funny romantic sexy smart passionate good looking good listener i would not date timothy is there anything you want to say about concerning dating   optional you are responsible for your submissions which must be true lawful and not violate any persons rights you agree to our user agreement how do you know timothy friends friend professional dating family member neighbor school club or organization religious myself not sure dont know them other     post anonymously  post review × two ways to improve your score correct and edit your extended background details correct  edit ask family  friends for positive reviews send an email share on facebook × × search to find background reports  publicly exposed personal details on anyone including yourself are you timothy barabe yes see  control your exposed background info see monitor  enhance your background report that people are viewing no see public background info on timothy  see background report to learn the truth about timothy  × thank you we received your vote × get an additional premium report on timothy barabe premium data contains highly sensitive info such as arrest records wealth  assets lawsuits  liens licenses  permits sexual offenses corp affiliations in order to access the sensitive info on a premium report today an additional fee is required remember you do not need to purchase a premium report to access the info that is available in standard reports buy premium report for no thank you thank you for your purchase your premium report is now ready click here to see report there is a problem authorizing your charge on this card please try your card again or try another card credit card no expiry date mm         9    year   9          9     cvc buy premium report for × you now have access to view timothy barabes premium background report the information in this report is gathered from government social  public records gathered from across the web access timothys premium background report × mylife protects  builds your reputation mylife gathers uptodate government social  public records so you know whats public everywhere online and help you build your reputation for employers friends and others that search for you here and on google we recommended you edit  correct your background report complete your profile providing positive details ask friends for positive reviews see whos checking your background remove unwanted records you cant control × review posted register to get reply alerts new to mylife register today for free already a member  log in name email we respect your privacy message register to send your email gender i am male female birthday mm         9    dd yyyy must be  years or older to join zip code password confirm password find my page by clicking on the button above you agree to our user agreement  privacy policy see  monitor all background info thats public on anyonewell show you all background information personal reviews and other details from government records and proprietary sources across the web plus alert you to changes edit and addto your background info personal reviews and social postscontrol your public details to look good to employers clients friends and anyone who finds you online send messages to get in touch with anyoneget complete contact info on anyone send unlimited messages to make valuable professional and personal contacts × sign up for free see detailed background info for timothy barabe already a member log in view full details by clicking on the button above you agree to our user agreement  privacy policy must be  years or older to join monitor your personal info  background report thats public make sure its accurate edit your background info  personal reviewsviewed by employers clients friends or anyone see whos searching for you ® employers friends lovers stalkers and others are looking for you remove private information thats exposed stop sites from selling your private details online send message to anyone get complete contact info on anyone make valuable professional and personal contacts send message to anyone get complete contact info on anyone make valuable professional and personal contacts monitor your personal info  background report thats public make sure its accurate edit your background info  personal reviewsviewed by employers clients friends or anyone see whos searching for you ® employers friends lovers stalkers and others are looking for you remove private information thats exposed stop sites from selling your private details online � send a message to timothy compose your message your name from message send your message by clicking on the button above you agree to our user agreement  privacy policy × sign up for free see detailed background info for timothy barabe already a member log in view full details by clicking on the button above you agree to our user agreement  privacy policy must be  years or older to join monitor your personal info  background report thats public make sure its accurate edit your background info  personal reviewsviewed by employers clients friends or anyone see whos searching for you ® employers friends lovers stalkers and others are looking for you remove private information thats exposed stop sites from selling your private details online send message to anyone get complete contact info on anyone make valuable professional and personal contacts send message to anyone get complete contact info on anyone make valuable professional and personal contacts monitor your personal info  background report thats public make sure its accurate edit your background info  personal reviewsviewed by employers clients friends or anyone see whos searching for you ® employers friends lovers stalkers and others are looking for you remove private information thats exposed stop sites from selling your private details online find anyone find anyone a b c d e f g h i j k l m n o p q r s t u v w x y z company about us testimonials press careers contact us blog faqs services monitor your identity remove your public profiles background check see whos searching for you connect with friends  find people manage your membership directories people search visit us on copyright  sun jul   pdt  mylifecom® inc  user agreement  privacy policy us patent no  and   the other websites referenced on this site are owned and operated by their respective companies and the associated trademarks and logos are the property of those companies links are provided for reference only and mylifecom® does not imply any connection or relationship between mylifecom® and these companies selecta biosciences appoints timothy c barabe to board of directors  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use 99 thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street selecta biosciences appoints timothy c barabe to board of directors globenewswire aug    am edt watertown mass aug   globe newswire  selecta biosciences inc nasdaqselb a clinicalstage biopharmaceutical company developing targeted antigenspecific immune therapies for rare and serious diseases today announced the election of timothy c barabe to the companys board of directors most recently serving as chief financial officer and executive vice president at affymetrix inc mr barabe has extensive experience in the life sciences industry having held a broad range of financial and strategic roles we are very pleased to welcome tim to our board tim is an industry veteran with decades of strong strategic and financial experience in the life sciences industry said werner cautreels phd chairman ceo and president of selecta biosciences tims exceptional grasp of the commercial and financial opportunities and challenges entailed in financing and growing selecta will add significant strategic perspectives as we seek to advance candidates from selectas pipeline portfolio in development i am very excited to be joining selectas board of directors at this pivotal time as the company applies its novel technologies to generate a robust pipeline of candidates said mr barabe selectas novel immune therapies offer significant opportunities for the company to provide patients providers and payors with meaningful new treatment options to address rare and serious diseases mr barabe has more than  years of experience in the life sciences industry he served as the chief financial officer and executive vice president at affymetrix inc where he led the companys financial functions as well as the treasury investor relations and information technology departments previously he served as senior vice president and chief financial officer at human genome sciences where he was responsible for working with the leadership team to drive the financial strategy and operations of the company for more than  years he held senior international executive roles in finance general management and strategic planning at novartis ag one of the worlds largest pharmaceutical companies his roles included chief financial officer of the sandoz generics business unit president of the ciba vision corporation specialty lens business franchise and group vice president and chief financial officer of ciba vision corporation mr barabe has a bba in finance from the university of massachusetts amherst and an mba from the university of chicago he also serves as a director of several public company boards including arqule opexa therapeutics and vigilant biosciences trending trump just resurrected the ugly practice known as civil forfeiture for no reason ftc seen as set to block rite aid deal  reasons dying sears had to strike a deal with the ruthless amazon starbucks has an alarming problem that even its fans must admit has to be fixed  and soon sears just surrendered to amazon with kenmore deal advertising partners 99 thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied opxaw timothy c barabe insider trades for opexa therapeutics inc wt bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close opexa therapeutics inc wt nasdaq opxaw go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus opexa therapeutics inc wt after hours  quotes are delayed by  min jul    pm opxaw quoteszigmancomposite   change 9  volume volume 9 quotes are delayed by  min quoteszigmancomposite previous close  9  9 change   day low day high  9  week low  week high   insider activity individual timothy c barabe mr timothy c barabe is independent director at opexa therapeutics inc and independent director at arqule inc he is on the board of directors at veeva systems inc vigilant biosciences inc opexa therapeutics inc arqule inc and project open hand inc mr barabe was previously employed as chief financial officer  executive vice president by affymetrix inc chief financial officer  senior vice president by human genome sciences inc managing directorunited kingdom by mölnlycke health care group ab chief financial officer by regent medical ltd presidentspecialty lens business franchise by ciba vision corp finance director by cibageigy corp and chief financial officer by sandoz international gmbh he received his undergraduate degree from the university of massachusetts and an mba from the university of chicago transactions date shares transaction value  9   disposition at  per share 9     disposition at  per share 9 9    award at  per share      award at  per share      award at  per share      award at  per share  9    award at  per share      award at  per share      derivativenonderivative trans at  per share      award at  per share  9    acquisition at  per share  9    award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr neil k warma president chief executive officer cfo  director dr hanspeter hartung independent director mr timothy c barabe independent director ms gail j maderis independent director mr michael s richman independent director trending tickers quoteszigman9composite vuzi quoteszigmancomposite jcp quoteszigman99composite nugt9 quoteszigmancomposite tlt quoteszigman9composite jnug x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service 9pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now loading more headlines dow quoteszigman9realtime    nasdaq quoteszigman9realtime    sp  quoteszigmanrealtime  9  kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml  99 99 lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  timothy barabe  affymetrix  inc  zoominfocom